[Letter: The prevention of the undesired physical adverse effects in the therapy with psychotropic drugs].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control*; D001523:Mental Disorders / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002800:Cholinesterase Inhibitors; D011619:Psychotropic Drugs
Zur Vermeidung unerwünschter körperlicher Nebenwirkungen bei der Therapie mit Psychopharmaka